Swiss Rock Aktien Europa X

Reference Data

ISIN LU1048648130
Valor Number 25008424
Bloomberg Global ID
Fund Name Swiss Rock Aktien Europa X
Fund Provider Swiss Rock Asset Management AG Zürich, Switzerland
Phone: +41 44 360 57 00
E-Mail: info@swiss-rock.ch
Web: www.swiss-rock.ch
Fund Provider Swiss Rock Asset Management AG
Representative in Switzerland Swiss Rock Asset Management AG
Zürich
Phone: +41 44 360 57 00
Distributor(s) Swiss Rock Asset Management AG
Zürich
Phone: +41 44 360 57 00
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** Top tier performance in european equity with a rock solid investment approach, rotating investment styles.
Peculiarities

Fund Prices

Current Price * 22.85 EUR 01.08.2025
Previous Price * 23.32 EUR 31.07.2025
52 Week High * 23.68 EUR 06.06.2025
52 Week Low * 19.74 EUR 09.04.2025
NAV * 22.85 EUR 01.08.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 47,920,792
Unit/Share Assets *** 1,624,268
Trading Information SIX

Performance

YTD Performance +9.02% 31.12.2024
01.08.2025
YTD Performance (in CHF) +8.07% 31.12.2024
01.08.2025
1 month -1.08% 01.07.2025
01.08.2025
3 months +0.62% 02.05.2025
01.08.2025
6 months +3.68% 03.02.2025
01.08.2025
1 year +9.23% 01.08.2024
01.08.2025
2 years +27.73% 01.08.2023
01.08.2025
3 years +40.44% 01.08.2022
01.08.2025
5 years +78.94% 03.08.2020
01.08.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

SAP SE 3.05%
Novartis AG Registered Shares 2.65%
ASML Holding NV 2.44%
Novo Nordisk AS Class B 2.17%
HSBC Holdings PLC 2.05%
Siemens AG 1.96%
AstraZeneca PLC 1.79%
Allianz SE 1.60%
Unilever PLC 1.59%
Roche Holding AG 1.53%
Last data update 31.03.2025

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee ***
Ongoing Charges *** 0.28%
SRRI ***
SRRI date *** 30.06.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)